Genomic Vision (FRA:G09) Total Stockholders Equity : €-2.77 Mil (As of Jun. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Genomic Vision Total Stockholders Equity?

Genomic Vision's Total Stockholders Equity for the quarter that ended in Jun. 2023 was €-2.77 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Genomic Vision's Book Value per Share for the quarter that ended in Jun. 2023 was €-0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Genomic Vision's Debt-to-Equity for the quarter that ended in Jun. 2023 was -0.35.

Genomic Vision Total Stockholders Equity Historical Data

The historical data trend for Genomic Vision's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomic Vision Total Stockholders Equity Chart

Genomic Vision Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

4.17

3.23

3.12

3.07

-1.29

Genomic Vision Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Stockholders Equity	Get a 7-Day Free Trial															3.78	3.07	0.48	-1.29	-2.77

Genomic Vision (FRA:G09) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Genomic Vision's Book Value per Share for the quarter that ended in Jun. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-2.771	-	0)	/	385.106
	=	-0.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Genomic Vision's Debt-to-Equity for the quarter that ended in Jun. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.197	+	0.785)	/	-2.771
	=	-0.35

Genomic Vision Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Genomic Vision's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomic Vision (FRA:G09) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genomic Vision SA (FRA:G09) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

80-84 rue des Meuniers, Green Square, Batiment E, Bagneux, FRA, 92220

Website

http://www.genomicvision.com

Genomic Vision SA is a molecular diagnostics and technology company specialized in the development of single DNA detection tools for research and in vitro diagnostics.

Genomic Vision (FRA:G09) Headlines

No Headlines